Life Science Investor Merlin Nexus Seeks $100 million Fund IV - Filing - Corrected
Life science funds that invest in both private companies and PIPE (private investment in public equity) deals seem to be gaining traction. Merlin Nexus, a New York firm with a mixed public and private portfolio, is the latest to file plans for a follow-on fund.
8 March 2012•3 mins read
